Since then, researchers have shown more and more convincingly that the weight loss effects of GLP-1 agonists are mediated through the brain a separate mechanism from its impact on blood glucose
As these drugs occupy a growing share of fill-finish capacity, contract development and manufacturing organisations (CDMOs) are responding by expanding their facilities and acquiring smaller competitors
Ozempic: The truth about new 'weight-loss' drugs - UCHealth, accessed April 22, 2025,
Contraindications GLP-1s arent recommended for those with a history of thyroid carcinoma, pancreatitis, some endocrine conditions, and GI motility disorders
I liked that I felt like I was getting adequate amounts of protein, carbs, and fats to satiate me, and that the meals never felt one-note